Maritschnegg E, Wang Y, Pecha N, Horvat R, Van Nieuwenhuysen E, Vergote I, Heitz F, Sehouli J, Kinde I, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Speiser P, Zeillinger R. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study. Journal of Clinical Oncology 2015 Dec 20;33(36):4293-300. ⇒paper

Ober­mayr E, Cac­sire Castillo-​Tong D, Pils D, Speiser P, Braicu I, Van Gorp T, Mah­ner S, Sehouli J, Ver­gote I, Zeillinger R (2012). Mol­e­c­u­lar char­ac­ter­i­za­tion of cir­cu­lat­ing tumor cells in patients with ovar­ian can­cer improves their prog­nos­tic sig­nif­i­cance – a study of the OVCAD con­sor­tium. Gynecol Oncol. 2013 Jan;128(1):1521. ⇒paper

Ober­mayr E, Sanchez-​Cabo F, Tea MKM, Singer CF, Krainer M, Fis­cher MB, Sehouli J, Reinthaller A, Hor­vat R, Heinze G, Tong D, Zeillinger R (2010). Assess­ment of a six gene panel for the mol­e­c­u­lar detec­tion of cir­cu­lat­ing tumor cells in the blood of female can­cer patients. BMC Can­cer 10: 666. ⇒down­load pdf

Pils D, Tong D, Hager G, Ober­mayr E, Heinze G, Kohl M, Schus­ter E, Wolf A, Schiebel I, Sehouli J, Braicu I, Ver­gote I, Van Gorp T, Mah­ner S, Concin N, Speiser P, Zeillinger R (2013). A com­bined blood based gene expres­sion and plasma pro­tein abun­dance sig­na­ture for diag­no­sis of epithe­lial ovar­ian can­cer — A study of the OVCAD con­sor­tium. BMC Can­cer. 2013 Apr 3;13:178. ⇒ down­load pdf